bpc-157 for cancer Is BPC-157 Peptide Safe? |
Description
[47:07] Dr
doi: 10.1021/acsptsci.0c00081
Keep an eye on how your treatment is going and change it if needed
During Phase I/II trials, patients reported adverse events similar to those of other vaccine candidates, including injection site pain, rash, headaches, muscle pain, fever, nausea and vomiting
A patient through age 18 who receives a vaccine without documented counseling stays on procedure code 90471
Both are damaging
